Access Bio, Inc. (KOSDAQ:950130)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,415.00
-70.00 (-2.01%)
Apr 30, 2026, 3:30 PM KST

Access Bio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
122,581133,661182,552302,841414,360569,632
Market Cap Growth
-35.10%-26.78%-39.72%-26.91%-27.26%-27.38%
Enterprise Value
-236,273-217,197-114,354-43,387-123,881568,975
Last Close Price
3485.003800.005190.008970.0012200.0014944.24
PE Ratio
----1.203.00
Forward PE
-22.6722.6722.6722.6722.67
PS Ratio
3.924.281.620.870.401.13
PB Ratio
0.220.240.280.520.661.96
P/TBV Ratio
0.220.240.280.520.671.99
P/FCF Ratio
--10.23-1.184.40
P/OCF Ratio
--9.17-1.123.48
EV/Sales Ratio
-----1.13
EV/EBITDA Ratio
-----2.14
EV/EBIT Ratio
-----2.19
EV/FCF Ratio
7.63----4.40
Debt / Equity Ratio
0.080.080.100.130.120.24
Debt / EBITDA Ratio
--8.831.930.160.26
Debt / FCF Ratio
--3.70-0.220.54
Net Debt / Equity Ratio
-0.64-0.64-0.60-0.47-0.68-0.45
Net Debt / EBITDA Ratio
7.667.66-52.01-7.23-0.88-0.49
Net Debt / FCF Ratio
11.6311.63-21.782.24-1.21-1.01
Asset Turnover
0.050.050.160.441.561.65
Inventory Turnover
3.283.282.132.442.542.65
Quick Ratio
16.3716.3711.498.383.011.85
Current Ratio
17.4217.4212.389.513.652.37
Return on Equity (ROE)
-13.72%-13.72%-0.17%-0.87%76.35%100.91%
Return on Assets (ROA)
-5.95%-5.95%-1.10%1.74%44.09%53.02%
Return on Invested Capital (ROIC)
-28.61%-27.80%-4.37%8.49%194.80%157.96%
Return on Capital Employed (ROCE)
-11.00%-11.00%-1.80%3.40%67.90%85.50%
Earnings Yield
-66.99%-61.44%-0.19%-1.05%83.66%33.30%
FCF Yield
-25.27%-23.17%9.78%-40.45%84.58%22.72%
Buyback Yield / Dilution
-41.84%-41.84%26.52%10.73%-1.46%-7.75%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.